Ciliatech appoints world-class panel of eyecare specialists to newly created KOL advisory board
Ciliatech will leverage ophthalmic expertise of seven-member advisory board to bring to market Intercil® Uveal Spacer, a novel glaucoma implant offering unique benefits to eye surgeons and patients across the globe Ciliatech, an innovative medtech company focusing on the treatment...
LambdaVision aims to refine process for in-space manufacturing of artificial retinas through ISS National Lab-sponsored investigation
1 February 2024
|
ISS, retinal, artificial, LambdaVision, industry, innovation, retinitis pigmentosa, RP
Approximately 1.5 million people worldwide are affected by retinitis pigmentosa, a rare genetic disorder that causes vision loss. Currently there is no cure, but researchers from LambdaVision are turning to the International Space Station (ISS) National Laboratory to look for...
Quantum technology first in eye disease detection
8 January 2024
|
quantum, AMD, disease prevention, Age-related macular degeneration, CEVR, innovation
Scientists are working on a new device that could lead to a reduction in the number of people who go blind from age-related macular degeneration (AMD).
Tech supplier search to help tackle 8am rush at GP surgeries
10 November 2023
|
NHS England, Digital Pathways Framework, Mark Sayers, digital technology, innovation, Appointments
Tech specialists are being sought to help tackle the 8am rush for appointments at GP surgeries.
Researchers pursue personalised pathways for glaucoma care
25 September 2023
|
glaucoma, Health Care Quality, research, innovation, Giovanni Montesano, RCOphth, glaucoma uk
Researchers, funded by Glaucoma UK in partnership with The Royal College of Ophthalmologists, are investigating the potential for personalised glaucoma care by mapping clinical trial data and real-word outcomes to individuals.
